Retrospective study assessing bleeding outcomes in patients with gastrointestinal malignancies treated with distally absorbed versus proximally absorbed direct oral anticoagulants
Latest Information Update: 31 Jan 2022
At a glance
- Drugs Apixaban (Primary) ; Dabigatran etexilate (Primary) ; Edoxaban (Primary) ; Rivaroxaban (Primary)
- Indications Venous thromboembolism
- Focus Adverse reactions
Most Recent Events
- 31 Jan 2022 New trial record
- 14 Dec 2021 Results presented at the 63rd American Society of Hematology Annual Meeting and Exposition